Immunic IMUX
NASDAQ IMUX
$8.08 -0.56 (-6.53%)
As of: Oct 2, 2026 · 11:23 AM EDT

Immunic (IMUX) Long-Term Debt Issuances (2024 - 2025)

Updated

Immunic (IMUX) posted Long-Term Debt Issuances of $65.4 million for FY2025, down 12.0% from $74.27 million in FY2024.

Analysis

Immunic (IMUX) Long-Term Debt Issuances (2024 - 2025) Analysis & Trends

  • The FY2025 figure stands as the lowest annual Long-Term Debt Issuances since FY2012.
  • Business Quant data shows IMUX's Long-Term Debt Issuances at $74.27 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Immunic 395.38 Mn 395.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 65.40 Mn
Mar 31, 2024 74.27 Mn
API Access

Immunic Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=IMUX&period=max&api_key=YOUR_API_KEY